본문 바로가기
KERD
논문KCI 등재

加味消風散이 염증 및 아토피피부염 동물병태에 미치는 영향

Effect of Gami-sopungsan on Inflammation and DNCB-induced Dermatitis in NC/Nga in Mice

2

조회

0

다운로드

36

인용

0

참고문헌

키워드

주제분류한의학

초록

Gami-Sopungsan (GS) is one of the traditional korean remedy. We investigated the anti-inflammation and anti-atopic dermatitis (AD) effect of GS. No cytotoxicity of GS was observed in the range of 1~100 ㎍/㎖ on Raw 264.7 cells. The Inflammatory response of Raw 264.7 cells were induced by lipopolysaccharide (LPS), followed by GS treatment at indicated concentrations (0, 1, 10 and 100 ㎍/㎖). At 100 ㎍/㎖ concentration, GS showed inhibitory effect on LPS-induced nitric oxide production by 20%. Production of IL-1β, IL-6 and TNF-α was decreased by approximately 56%, 36% and 79%, respectively upon GS treatment at 100 ㎍/㎖. 200 ㎎/㎏ of GS was orally administered to NC/Nga mice, where AD was induced by 1-chloro 2,4-dinitrobenzene. There were no significant difference between GS treated group and the control group on body weight and food intake changes during growth. The back skin of GS group showed decrease in erythema, pruritus, dry skin, edema, excoriation, erosion and lichenification level through naked eye observations. In addition, leukocyte infiltration and the thickness of epidermis were significantly decreased in the skin tissues (back and ear). The serum IgE levels were decreased by 28.8% in the GS treated group. The GS treated group showed remarkable inhibition of IL-4 (83%), IL-5 (95%), IL-6 (62%) and TNF-α (84%) in serum, indicating that GS has similar or higher efficacy than those of the dexamethasone treated group. From the results above, we conclude that GS has significant anti-inflammation and anti-AD effects on Raw 264.7 cells and NC/Nga mice. The results should provide fundamental and valuable data for the research on natural products being developed against atopic dermatitis.

Abstract

Gami-Sopungsan (GS) is one of the traditional korean remedy. We investigated the anti-inflammation and anti-atopic dermatitis (AD) effect of GS. No cytotoxicity of GS was observed in the range of 1~100 ㎍/㎖ on Raw 264.7 cells. The Inflammatory response of Raw 264.7 cells were induced by lipopolysaccharide (LPS), followed by GS treatment at indicated concentrations (0, 1, 10 and 100 ㎍/㎖). At 100 ㎍/㎖ concentration, GS showed inhibitory effect on LPS-induced nitric oxide production by 20%. Production of IL-1β, IL-6 and TNF-α was decreased by approximately 56%, 36% and 79%, respectively upon GS treatment at 100 ㎍/㎖. 200 ㎎/㎏ of GS was orally administered to NC/Nga mice, where AD was induced by 1-chloro 2,4-dinitrobenzene. There were no significant difference between GS treated group and the control group on body weight and food intake changes during growth. The back skin of GS group showed decrease in erythema, pruritus, dry skin, edema, excoriation, erosion and lichenification level through naked eye observations. In addition, leukocyte infiltration and the thickness of epidermis were significantly decreased in the skin tissues (back and ear). The serum IgE levels were decreased by 28.8% in the GS treated group. The GS treated group showed remarkable inhibition of IL-4 (83%), IL-5 (95%), IL-6 (62%) and TNF-α (84%) in serum, indicating that GS has similar or higher efficacy than those of the dexamethasone treated group. From the results above, we conclude that GS has significant anti-inflammation and anti-AD effects on Raw 264.7 cells and NC/Nga mice. The results should provide fundamental and valuable data for the research on natural products being developed against atopic dermatitis.

참고문헌 (36)

  1. Tanaka, K., "Environmental factors and allergic disorders", Allergol. Int., 56, pp.363~396 (2007)
  2. Morar, N., "The genetics of atopic dermatitis", J. Allergy Clin. Immunol., 118, pp.24~34 (2006)
  3. Leung, D.Y., "Atopic dermatitis", Lancet, 361, pp.51~160 (2003)
  4. Sicherer, S.H., "Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects", J. Allergy Clin. Immunol., 121, pp.1351~1358 (2008)
  5. 박용민, "아토피피부염 역학조사와 위험인자", Allergy Asthma & Respiratory Diseases, 21(2), pp.74~77 (2011), 대한 소아알레르기 호흡기학회
  6. James, J.M., "Patients with severe atopic dermatitis have activated circulating basophils", J. Allergy Clin. Immunol., 91(6), pp.1155~1162 (1993)
  7. Burks, A.W., "Atopic dermatitis and food hypersensitivity reactions", J. Pediatr., 132(1), pp.132~136 (1998)
  8. Natalija Novak, "Immune mechanisms leading to atopic dermatitis", J. Allergy Clin. Immunol., 112, pp.128~139 (2003)
  9. Lee-Rang Im, "Inhibitory Effect of Kyungohkgo in the Development of 2,4-Dinitrochlorobenzene-induced Atopic Dermatitis in NC", Nga Mice, 2011, pp.34(2), 317~321[DOI]
  10. Jun, H., "Donguibogam", pp.57~, Yeo-gang Republic
  11. 박숙자, "소풍산물추출물이 DNCB로 유발된 접촉성피부염에 미치는 영향", 동의생리병리학회지, 20(3), pp.623~628 (2006), 대한동의병리학회
  12. 황보민, "지루성피부염 치험1례", 한방안이비인후피부과학회지, 18(3), pp.142~147 (2005), 대한한방안이비인후피부과학회
  13. 임광모, "알레르기성 질환에 대한 한의학적 접근", 동의생리병리학회지, 16(5), pp.1~839 (2002), 대한동의병리학회
  14. 서형식, "消風導赤湯과 四物消風散의 항염 및 항산화 효과에 대한 실험적 연구", Journal of Pharmacopuncture, 13(1), pp.79~85 (2010), 대한약침학회
  15. 박정숙, "백선피의 iNOS발현과 염증성사이토카인의 생성에 미치는 영향", 생약학회지, 42(4), pp.348~353 (2011), 한국생약학회
  16. 김나영, "지부자 활성성분이 D-Galactosamine 투여에 의한 흰쥐의 간손상에 미치는 영향", 한국식품영양과학회지, 33(8), pp.1286~1293 (2004), 한국식품영양과학회
  17. 김정선, "지부자 피부도포가 히스타민 유발 소양감, 홍반, 팽진에 미치는 영향", 대한한의학회지, 24(1), pp.133~140 (2003), 대한한의학회
  18. 양한열, "형개 추출물의 항산화 활성 및 Tyrosinase 저해 활성에 대한 원적외선 처리의 효과", 한국식품영양과학회지, 42(9), pp.1357~1362 (2013), 한국식품영양과학회
  19. 황은영, "홍화자, 향부자, 형개 추출물의 미백효과에 관한 연구", 한국식품과학회지, 44(1), pp.76~81 (2012), 한국식품과학회
  20. 이승은, "대장균과 살모넬라균에 대한 박하와 배초향 정유성분의 향균활성", 한국약용작물학회지, 10(3), pp.206~211 (2002), 한국약용작물학회
  21. Shin, T.Y., "Antiallergic Anctivity of Menthae Herba", Kor. J. Pharmacogn., 29(3), pp.248~253 (1998)
  22. 이승은, "박하의 in vitro 항산화활성", 한국약용작물학회지, 13(6), pp.255~260 (2005), 한국약용작물학회
  23. Matsumoto, M., "IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC", Nga mice, a model for human atopic dermatitis, 1999, pp.162, 1056~1063
  24. Suto, H., "NC", Nga mice: A mouse model for atopic dermatitis, 1999, pp.120, 70~75
  25. Hoffman, E.S., "From the analyst's couch: TLR-targeted therapeutics", Nature review drug discovery, 4(11), pp.879~880 (2005)
  26. Yun, K. J., "Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-κB inactivation in Raw 264.7 macrophages: Possible involvement of the IKK and MAPK pathways", Int. Immunophar., 8, pp.431~441 (2008)
  27. Baugh, J.A., "Mechanisms for modulating TNF-α in immune and inflammatory disease", Current opinion in drug discovery and development, 4, pp.635~650 (2001)
  28. 이덕재, "사매 에탄올 추출물의 항 알레르기 효과", 동의생리병리학회지, 26(6), pp.902~907 (2012), 대한동의병리학회
  29. Roitt, I., "Immunology", pp.119~ (2002), Mosby
  30. Zhang, Y., "Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis", Science, 258, pp.1957~1959 (1992)
  31. Gabay, C., "Interleukin-6 and chronic inflammation", Arthritis Research & Therapy, 8, pp.1~3 (2006)
  32. van Triel, J.J., "Allergic inflammation in the upper respiratory tract of the rat upon repeated inhalation exposure to the contact allergen dinitrochlorobenzene (DNCB)", Toxicology, 269, pp.73~80 (2010)
  33. Bradding, P., "Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation", J. Immunol., 151(7), pp.3853~3865 (1993)
  34. Sasakawa, T., "Atopic dermatitis-like skin lesions induced by topical application of mite antigens in NC", Nga mice, 2001, pp.126, 239~247
  35. Budde, I.K., "Studies on the association between immunoglobulin E autoreactivity and immunoglobulin E-dependent histamine-releasing factors", Immunol., 107, pp.243~251 (2002)
  36. Tepper, R.I., "IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice", Cell, 62(3), pp.457~467 (1990)

관련 논문AI추천

이 간행물의 다른 논문 (15건)